These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

121 related articles for article (PubMed ID: 3779323)

  • 21. Resistance to 6-thioguanine in mismatch repair-deficient human cancer cell lines correlates with an increase in induced mutations at the HPRT locus.
    Glaab WE; Risinger JI; Umar A; Barrett JC; Kunkel TA; Tindall KR
    Carcinogenesis; 1998 Nov; 19(11):1931-7. PubMed ID: 9855005
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Hprt activities and RNA phenotypes in 6-thioguanine resistant human T-lymphocytes.
    Steen AM; Sahlén S; Hou SM; Lambert B
    Mutat Res; 1993 Apr; 286(2):209-15. PubMed ID: 7681532
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Cytostatic drugs in the treatment of rheumatic and connective tissue diseases].
    Martio J
    Duodecim; 1998; 114(3):243-51. PubMed ID: 10895494
    [No Abstract]   [Full Text] [Related]  

  • 24. Molecular analysis of spontaneous hypoxanthine phosphoribosyltransferase mutations in thioguanine-resistant HL-60 human leukemia cells.
    Monnat RJ
    Cancer Res; 1989 Jan; 49(1):81-7. PubMed ID: 2908855
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Analysis of mutational effects at the HPRT locus in human G(0) phase lymphocytes irradiated in vitro with gamma rays.
    Mognato M; Ferraro P; Canova S; Sordi G; Russo A; Cherubini R; Celotti L
    Mutat Res; 2001 Mar; 474(1-2):147-58. PubMed ID: 11239972
    [TBL] [Abstract][Full Text] [Related]  

  • 26. T-cell cloning to detect the mutant 6-thioguanine-resistant lymphocytes present in human peripheral blood.
    Albertini RJ; Castle KL; Borcherding WR
    Proc Natl Acad Sci U S A; 1982 Nov; 79(21):6617-21. PubMed ID: 6983072
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lymphocyte Hprt mutant frequency and sperm toxicity in C57BL/6 mice treated chronically with Azathioprine.
    Bendre SV; Shaddock JG; Patton RE; Dobrovolsky VN; Albertini RJ; Heflich RH
    Mutat Res; 2005 Oct; 578(1-2):1-14. PubMed ID: 16107271
    [TBL] [Abstract][Full Text] [Related]  

  • 28. In vivo mutant frequency of thioguanine-resistant T-cells in the peripheral blood and lymph nodes of melanoma patients.
    Albertini MR; King DM; Newton MA; Vacek PM
    Mutat Res; 2001 May; 476(1-2):83-97. PubMed ID: 11336986
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Nephrotic syndrome due to primary renal disease. Study of therapeutic response (author's transl)].
    Casado S; Ruilope LM; Oliva H; Hernando L
    An Esp Pediatr; 1974; 7(2):124-30. PubMed ID: 4849232
    [No Abstract]   [Full Text] [Related]  

  • 30. [Immunosuppressive therapy of the nephrotic syndrome in childhood].
    Brodehl J
    Monatsschr Kinderheilkd (1902); 1972 Jun; 120(6):223-32. PubMed ID: 4560226
    [No Abstract]   [Full Text] [Related]  

  • 31. Colonic microbiota can promote rapid local improvement of murine colitis by thioguanine independently of T lymphocytes and host metabolism.
    Oancea I; Movva R; Das I; Aguirre de Cárcer D; Schreiber V; Yang Y; Purdon A; Harrington B; Proctor M; Wang R; Sheng Y; Lobb M; Lourie R; Ó Cuív P; Duley JA; Begun J; Florin TH
    Gut; 2017 Jan; 66(1):59-69. PubMed ID: 27411368
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Mutational spectra at the hypoxanthine-guanine phosphoribosyltransferase (HPRT) locus in T-lymphocytes of nonsmoking and smoking lung cancer patients.
    Hackman P; Hou SM; Nyberg F; Pershagen G; Lambert B
    Mutat Res; 2000 Jun; 468(1):45-61. PubMed ID: 10863157
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Childhood nephrotic syndrome with minimun glomerular lesions (clinical development and therapeutic response in 40 cases)].
    Ruilope LM; Casado S; López de Novales E; Barat A; Alvarez J; Hernando L
    Rev Clin Esp; 1973 Nov; 131(4):313-8. PubMed ID: 4772782
    [No Abstract]   [Full Text] [Related]  

  • 34. [Immunosuppressive therapy chronic polyarthritis].
    Thumb N
    Wien Z Inn Med; 1972 Dec; ():Suppl:1-52. PubMed ID: 4574028
    [No Abstract]   [Full Text] [Related]  

  • 35. Immunosuppressive and cytotoxic drugs in the treatment of rheumatic skin disorders.
    Callen JP
    Semin Cutan Med Surg; 2001 Mar; 20(1):58-68. PubMed ID: 11308138
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The clinical use of immunosuppressive drugs.
    Forbes IJ
    Med J Aust; 1973 Apr; 1(15):749-52. PubMed ID: 4707372
    [No Abstract]   [Full Text] [Related]  

  • 37. [Immunosuppressive treatment strategy in connective tissue diseases].
    Okada J; Kondo H
    Nihon Rinsho; 1999 Feb; 57(2):432-8. PubMed ID: 10078019
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Methyl DNA adducts, DNA repair, and hypoxanthine-guanine phosphoribosyl transferase mutations in peripheral white blood cells from patients with malignant melanoma treated with dacarbazine and hydroxyurea.
    Philip PA; Souliotis VL; Harris AL; Salisbury A; Tates AD; Mitchell K; van Delft JH; Ganesan TS; Kyrtopoulos SA
    Clin Cancer Res; 1996 Feb; 2(2):303-10. PubMed ID: 9816173
    [TBL] [Abstract][Full Text] [Related]  

  • 39. A mouse model for the study of in vivo mutational spectra: sequence specificity of ethylene oxide at the hprt locus.
    Walker VE; Skopek TR
    Mutat Res; 1993 Jul; 288(1):151-62. PubMed ID: 7686258
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Comparative toxicity of total lymphoid irradiation and immunosuppressive drug treated patients with intractable rheumatoid arthritis.
    Sherrer Y; Bloch D; Strober S; Fries J
    J Rheumatol; 1987 Feb; 14(1):46-51. PubMed ID: 3572934
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.